FilingReader Intelligence
Rossari Biotech reports Q1 consolidated income of INR 5.4bn
July 19, 2025 at 02:09 PM UTC•By FilingReader AI
Rossari Biotech reported consolidated income of INR 5,449.16 million for the quarter ended June 30, 2025, with profit after tax at INR 335.96 million.
The company posted standalone income of INR 3,675 million and profit after tax of INR 262.33 million for the same period.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
BSE:ROSSARI•Bombay Stock Exchange
News Alerts
Get instant email alerts when ROSSARI BIOTECH publishes news
Free account required • Unsubscribe anytime